Literature DB >> 6437990

Immunity against infection with Trypanosoma cruzi in mice correlates with presence of antibodies against three trypomastigote polypeptides.

H J Zweerink, H D Weston, O F Andersen, S S Garber, E C Hayes.   

Abstract

Repeated immunizations of CF1 mice with irradiated noninfectious Trypanosoma cruzi trypomastigotes resulted in partial protection against infection with live parasites. It also induced a limited number of antibody species that were reactive in Western blots with trypomastigote but not with epimastigote or amastigote polypeptides. These antibody species were strongly reactive with a 100,000-dalton polypeptide and much less reactive with at least two polypeptides greater than 200,000 daltons. Immunization with epimastigotes induced antibodies against a 57,000-dalton epimastigote-specific polypeptide but did not induce protective immunity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6437990      PMCID: PMC261620          DOI: 10.1128/iai.46.3.826-830.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Protective immunisation of mice using cell surface glycoprotein from Trypanosoma cruzi.

Authors:  M T Scott; D Snary
Journal:  Nature       Date:  1979-11-01       Impact factor: 49.962

Review 2.  American trypanosomiasis: Chagas' disease.

Authors:  C A Santos-Buch
Journal:  Int Rev Exp Pathol       Date:  1979

3.  GROWTH AND DIFFERENTIATION IN TRYPANOSOMA CRUZI. I. ORIGIN OF METACYCLIC TRYPANOSOMES IN LIQUID MEDIA.

Authors:  E P CAMARGO
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1964 May-Jun       Impact factor: 1.846

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Immunization of mice with irradiated Trypanosoma cruzi growth in cell culture: relation of numbers of parasites, immunizing injections, and route of immunization to resistance.

Authors:  W L Hanson; W L Chapman; V B Waits
Journal:  Int J Parasitol       Date:  1976-08       Impact factor: 3.981

6.  Antigens of subcellular fractions of Trypanosoma cruzi. III. Humoral immune response and histopathology of immunized mice.

Authors:  S M Gonzalez Cappa; A Bronzina; A M Katzin; H Golfera; G W De Martini; E L Segura
Journal:  J Protozool       Date:  1980-11

7.  Trypanosoma cruzi: selective isolation of pure trypomastigotes from cultured muscle cells.

Authors:  D M Schmatz; P K Murray
Journal:  J Parasitol       Date:  1981-08       Impact factor: 1.276

8.  Application of a novel radioimmunoassay to identify baculovirus structural proteins that share interspecies antigenic determinants.

Authors:  G E Smith; M D Summers
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

9.  Specific glycoprotein antigens on the surface of insect and mammalian stages of Trypanosoma cruzi.

Authors:  N Nogueira; J Unkeless; Z Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

10.  Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies.

Authors:  A U Krettli; Z Brener
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

View more
  4 in total

1.  Immunoblot analyses of Candida albicans-associated antigens and antibodies in human sera.

Authors:  M Manning-Zweerink; C S Maloney; T G Mitchell; H Weston
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

2.  Shift of excretory-secretory immunogens of Trypanosoma cruzi during human Chagas' disease.

Authors:  E E Jazín; A O Luquetti; A Rassi; A C Frasch
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Trypanosoma cruzi but not Trypanosoma brucei fails to induce a chemiluminescent signal in a macrophage hybridoma cell line.

Authors:  B Vray; P De Baetselier; A Ouaissi; Y Carlier
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

4.  Efficient expression of a Trypanosoma cruzi antigen in Escherichia coli and Staphylococcus aureus and its rapid purification.

Authors:  J I Moreno; M Seigelchifer; J Zorzópulos
Journal:  World J Microbiol Biotechnol       Date:  1991-05       Impact factor: 3.312

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.